Steris today announced that it will be investing $600 million to build a formulated chemistries manufacturing and distribution facility in North Carolina, near the Raleigh-Durham Research Triangle region.
The facility will serve as a central hub to produce infection prevention and contamination control chemistries used across the healthcare and pharmaceutical industries.
The construction of these facilities will include several phases, and the new site is expected to become operational in two to three years, starting with distribution. Upon completion, Steris expects to transition its existing manufacturing and distribution of chemistries from St. Louis, Missouri and Plymouth, Minnesota to this new facility.
This manufacturing investment is the largest in Steris history and was made after completing an evaluation of potential locations, including existing facilities. The 600,000 square-foot campus will create approximately 335 jobs in North Carolina for manufacturing, R&D, distribution and operations.
